课题基金 / 基金详情

项目摘要

项目成果

ELAINE M WORCESTER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Summary The project's broad objective is an understanding of the impact of two common treatments for stone disease on renal calcium (Ca) handling, and the links between renal physiology and tissue calcifications in stone formers (SF). Stone formation requires urine supersaturation (SS) with calcium oxalate (CaOx) and calcium phosphate (CaP); idiopathic hypercalciuria (IH) is a common cause of increased SS. Prevention of stone recurrence relies on decreasing SS, but the optimal means of doing this in a given patient is not clear. Decreased tubular Ca reabsorption (rCa), in both proximal and distal nephron, is characteristic of IH. We hypothesize that renal tubule transport alterations are linked to pathogenesis of the tissue calcifications found in SF, as well as to their stones, and propose to study Ca SF with IH (IHSF) who have undergone papillary mapping during endoscopy who will be selected for one of two papillary appearances: 1) papillae with abundant plaque but no plugging (typical of many CaOx SF) or 2) plugs with modest plaque (typical of apatite SF). We will test the hypothesis that plaque surface area correlates with decreased proximal tubule rCa, and plug area correlates with increased CaP SS (Aim 1.1a,b). Having demonstrated differences between IHSF and normals (N) in rCa on a stable diet, both fasting and fed, we propose to explore these findings using high and low Na intake, with or without Kcitrate. We will study the effects on rCa, fasting, fed and overnight (a high risk period for stone formation), using lithium clearance and urine stone risk factors (Aims 1.2a, 1.4a, 1.5). To understand the mechanisms of the changes in rCa that we expect with low Na diet and K citrate, we will measure urine exosomes for both proximal and distal nephron transporters (Aims 1.2b, 1.4, and 1.5). SS and upper limit of metastability will be measured to gain a better understanding of how K citrate and low Na diet affects these important treatment parameters (Aim 1.5, 1.6). To gain further insight into plaque and plug formation the role of inflammation (Aim 1.3).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Pathophysiology of Nephrolithiasis
  • 批准号:
    8231162
  • 项目类别:
  • 资助金额:
    $27.77万
  • 财政年份:
    2011
  • 负责人:
    ELAINE M WORCESTER
  • 依托单位:
CORE--ASSAY
  • 批准号:
    7490031
  • 项目类别:
  • 资助金额:
    $18.63万
  • 财政年份:
    2007
  • 负责人:
    ELAINE M WORCESTER
  • 依托单位:
CORE--ASSAY
  • 批准号:
    7311589
  • 项目类别:
  • 资助金额:
    $19.19万
  • 财政年份:
    2006
  • 负责人:
    ELAINE M WORCESTER
  • 依托单位:
CORE--ASSAY
  • 批准号:
    6898585
  • 项目类别:
  • 资助金额:
    $19.55万
  • 财政年份:
    2005
  • 负责人:
    ELAINE M WORCESTER
  • 依托单位:
国内基金
海外基金
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
  • 批准号:
    22007039
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    王黎明
  • 依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
  • 批准号:
    21172061
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2011
  • 负责人:
    许新华
  • 依托单位: